34.93
BATS BZX Real-Time Price
As of 10:17am ET
 +0.33 / +0.95%
Today’s Change
30.33
Today|||52-Week Range
47.82
-17.44%
Year-to-Date
J&J Gets Positive CHMP Opinion for Prostate Cancer Treatment
Nov 19 / Zacks.com - Paid Partner Content
Theravance (TBPH) Beats on Q3 Earnings, Inks Deal for Vibativ
Nov 08 / Zacks.com - Paid Partner Content
Acorda Down More Than 30% in the Past 3 Months: Here's Why
Nov 15 / Zacks.com - Paid Partner Content
Company News For Nov 7, 2018
Nov 07 / Zacks.com - Paid Partner Content
Momenta (MNTA) Reports Narrower-Than-Expected Loss in Q3
Nov 09 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close34.60
Today’s open34.79
Day’s range34.49 - 34.93
Volume102,461
Average volume (3 months)4,938,173
Market cap$17.8B
Data as of 10:17am ET, 11/20/2018

Growth & Valuation

Earnings growth (last year)+38.30%
Earnings growth (this year)+3.00%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+7.06%
P/E ratio33.5
Price/Sales1.91
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-2.58-2.75%
INCYIncyte Corp-0.59-0.92%
ALXNAlexion Pharmaceutic...-0.81-0.70%
JAZZJazz Pharmaceuticals...+2.45+1.71%
Data as of 10:17am ET, 11/20/2018

Financials

Next reporting dateFebruary 27, 2019
EPS forecast (this quarter)$1.42
Annual revenue (last year)$11.9B
Annual profit (last year)$696.0M
Net profit margin5.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts